We are live on
!
Find out more
WU
Washington University Portfolio holdings
AUM
$265M
1-Year Est. Return
9.03%
This Fund
S&P 500
This Quarter
Est. Return
-16.62%
1 Year Est. Return
-9.03%
3 Year Est. Return
+44.04%
5 Year Est. Return
+31.36%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$105M
(+65%)
Cap. Flow
+$123M
Cap. Flow
% of AUM
46.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
2
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBRS
Cerebras Systems
CBRS
|
+$130M |
| 2 |
Rubrik
RBRK
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MAZE
Maze Therapeutics
MAZE
|
+$8.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 53.31% |
| 2 | Technology | 46.69% |
| 3 | Healthcare | 0% |
Similar funds
BIA
NI
RCS
FH
TP
LWMI
WRTC
AFA
Washington University's Q2 2026 Portfolio in Review
As of Q2 2026, Washington University held 4 positions worth $265M, up 65% from $160M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Washington University deployed $123M of net new capital in Q2 2026, opening 2 new positions. Its largest new stake was Cerebras Systems: 551,086 shares worth $122M.
By sector, the portfolio is most concentrated in Financials at 53% of assets, down from 95% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the most notable exit was Maze Therapeutics, an estimated $8.38M sold.
- Washington University's largest Q2 2026 buy was Cerebras Systems: 551,086 shares worth $122M.
- Washington University fully exited Maze Therapeutics in Q2 2026, selling an estimated $8.38M.
- Washington University's ten largest holdings make up 100% of its $265M portfolio in Q2 2026.
- Washington University opened 2 new positions and closed 1 in Q2 2026.
- Washington University's portfolio value rose 65% quarter-over-quarter to $265M.
Based on Washington University's 13F filing for Q2 2026, filed 14 Jul 2026.